Category Archives: Opportunities

Job Alert: Senior Research Development and Commercialization Associate at NAU

Posted on by

NAU_PrimV_webCompany:

Northern Arizona University

Position:

Senior Research Development and Commercialization Associate

Job Description:

The Senior Research Development and Commercialization Associate is charged with sourcing, building and maintaining strong, productive relationships with faculty, staff and student researchers and innovators-as well as with existing/prospective licensees, industry partners, entrepreneurs, and the local, regional and national innovation management community-for the purpose of catalyzing research and technology development and pushing university innovations from the lab to the marketplace.  The Senior Research Development and Commercialization Associate participates in decision-making associated with institutional-level research investments and also manages an assigned portfolio of technologies from initial invention disclosure through the commercial life of the technologies.  Reports to the Chief of Staff, Office of the Vice President for Research and Director of NAU Innovations (one individual).

 

To learn more and apply, please click here.

Tallwave expands competition to include Health IT

Posted on by
Tallwave today announced it is opening applications in its latest High Tide(TM) competition to Healthcare IT entrepreneurs from across the country. These entrepreneurs will join peers applying for the program in the previously announced focus on innovations in Ed Tech. In addition, Tallwave has reserved four to six slots for Arizona-only IT companies regardless of the industry sector they hail from. The deadline for submission is March 31, 2014 and can be completed online at www.tallwavehightide.com .Continue reading→

Opportunity Alert – AZ Fast Grants 2014

Posted on by

ACA_HorzCMYK

The AZ Fast Grant competition

will open on Monday, March 10!

 

 

This competitive grant enables Arizona-based technology companies to initiate the commercialization process. Total funds available for this grant round are $175,000.

 

Maximum awards of $5,000 and $20,000 will enable companies to accomplish one of four scopes of work.

 

  1. SBIR/STTR Proposal Development (Maximum award $5,000)
  • Awardees will be automatically enrolled in our PIII Playbook training class with 23 hours of training and coaching. Cost per company to participate is $1,500. This will be paid from the AZ Fast Grant award. Services will be provided by consultants under contract with ACA.
  • We are providing an additional $3,500 to the awardee for SBIT/STTR proposal writing assistance. The awardee may hire any professional consultant to assist them.

 

  1. Commercialization Feasibility Study (Maximum award $5,000)  The awardee may hire any professional consultant to assist them.
  • Identify show stoppers to commercialization before resources are spent commercializing a technology that is unlikely to succeed.

 

  1. Other Acceptable Means of Technology Commercialization Assistance (Maximum award $5,000) The awardee may hire any professional consultant to assist them.
  • Technology Review – An expert review of the technology under development to determine if it already exists, is a good candidate for intellectual property protection and is likely to find an attractive market.
  • Requests for other acceptable means of technology commercialization assistance will be considered.

 

  1. Innovation in Manufacturing (Maximum award $20,000)
  • This award provides seed monies for the creation and proof of concept testing of disruptive tools and technologies to Arizona manufacturing firms in targeted business sectors.
  • Commercialization of these tools and technologies is our top goal.
  • Solution providers, i.e. – consultants, training firms, engineering and technology companies, and educational institutions, are required to team with manufacturers to submit proposals.
  • Each proposer must identify a teaming arrangement with Arizona manufacturers. Preference will be given to proposers teaming with multiple manufacturing partners.
  • Applicants and their manufacturing partners must leverage the award funds with a partial match of the requested award amount.
  • Applicants must demonstrate a 50% match (cash and in-kind) of the requested award amount. Preference will be given to applicants with higher cash to in-kind ratio.
  • Manufacturing partners must provide a total award match of at least 25% cash and/or in-kind, i.e. – labor, materials, machine time, plant overhead, etc. Preference will be given to applicants with higher industry in-kind contributions.
  • Match requirements for a theoretical award might look like:

 

Innovation in Manufacturing Award          $20,000

Proposer Match (50%)                            $10,000

Sub Total                                   $30,000

Total of Manufacturing Partners’ Match (25%)  $7,500

Total Grant Value                                          $37,500

 

Important Details

  • Applications must be completed on-line via the link on the AZ Fast Grant webpage .  
  • Closes on April 14 @ 5pm MST.
  • Awards will be announced in June.

NCI SBIR Direct to Phase II Pilot Program

Posted on by

Direct to Phase II Pilot Program is here!
Jump Into New Funding Opportunities Now

Finding funding to continue your innovative cancer research can be difficult. Luckily, there’s some good news.

The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center is implementing the SBIR Direct to Phase II Pilot solicitation, PAR-14-088, per the 2011 SBIR & STTR Reauthorization Act, allowing applicants that have demonstrated the R&D and technical merit characteristic of a Phase I (R43) SBIR project to bypass Phase I and apply directly for SBIR Phase II grants.

We encourage you to review the opportunity below and consider applying.

 


Direct Phase II Pilot Program

The NCI SBIR Development Center welcomes qualified applicants to participate in the newly authorized Direct-to-Phase II SBIR grant mechanism. This program applies to SBIR only, NOT STTR.This program is designed to expand opportunities for small business concerns and accelerate the pace of technology development and commercialization. Applicants that have demonstrated the R&D and technical merit characteristic of a Phase 1 (R43) SBIR project are encouraged to apply.

Standard deadlines apply. The next application receipt date is April 5, 2014, 5:00PM local time.

 


NIH SBIR and STTR applicants may now switch programs at Phase II or Phase IIB

  • Applicants may now switch between SBIR & STTR Programs. Those who previously were funded under an STTR Phase I award are now eligible to apply for an SBIR Phase II award and vice versa.
  • Those who previously were funded under an STTR Phase II award are now eligible to apply for an SBIR Phase IIB award and vice versa.

View the Application Guide for NIH and Other PHS Agencies for more information on preparing and submitting SBIR & STTR applications.

 


Recently ReleasedThe SBIR Phase IIB Bridge Award RFA is now live. Please apply by April 21, 2014, 5:00PM local time.

How to Apply
For resources and examples of SBIR grant applications and contract proposals, please visit http://sbir.cancer.gov/resource/apply/.

Please visit http://sbir.cancer.gov/ to learn more about the NCI SBIR & STTR Programs.

The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov

 

 

Opportunity Alert: 2014 NIH SBIR & STTR Omnibus Grant Solicitation for Small Businesses

Posted on by

National Cancer Institute

SBIR and STTR

Available Now!
2014 NIH SBIR & STTR Omnibus Grant Solicitation for Small Businesses

Are you a small business in need of funding to advance your novel cancer technology?
The 2014 SBIR and STTR Omnibus Grant Solicitation of the NIH is now live and the National Cancer Institute’s (NCI) budget for the program is increasing. Funding from the NCI Small Business Innovation Research & Small Business Tech Transfer (SBIR & STTR) Programs can help you advance your technology towards commercialization and can also help spark investor interest in your business.

The next application due date is April 5, 2014. We encourage you to start preparing your application and are happy to provide feedback on your project. If you’d like to take advantage of this opportunity, please email the NCI SBIR program director listed in your relevant technology area. Also be sure to check that all of your required registrations are complete. It’s never too early to start the registration process.

New changes in the 2014 Omnibus Solicitation include additional provisions of the 2011 SBIR & STTR Reauthorization Act, so please read the solicitations carefully.

  • Applicants may now switch between SBIR & STTR Programs. Those who previously were funded under an STTR Phase I award are now eligible to apply for an SBIR Phase II award, and vice versa.
  • Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms are eligible to apply to the NIH SBIR program. View frequently asked questions on VC participation. 

View the Application Guide for NIH and Other PHS Agencies for more information on preparing and submitting SBIR & STTR applications.

 
PHS 2014-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Receipt Dates: April 5, 2014; August 5, 2014; December 5, 2014PHS 2014-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Receipt Dates: April 5, 2014; August 5, 2014; December 5, 2014

Applications proposing innovative cancer-related technologies, with strong commercial potential, in a wide range of topic areas, are invited through the Omnibus Solicitations. Please visit the Research Topics of Interest page on the SBIR website to view the list of portfolio areas.  

NCI particularly encourages applications in the following 

  • Development of Low Cost Technologies for Global Health
  • Development of Companion Diagnostics
  • Vaccine Development for Cancer Prevention
  • Novel Technologies to Address “Undruggable” Drug Targets
  • New Technologies to Assess Tissue-Based Markers of Tumor Death and Mitochondrial Stress in Response to Therapy
Additional funding opportunities include:

 

Who is Eligible to Apply:
U.S. small business concerns: 

  • SBIR & STTR: Small business concerns that are more than 50% directly owned and controlled by one or more individuals, other business concerns, or any combination of these; OR be a joint venture in which each entity in the joint venture must meet certain requirements.
  • SBIR only: Small business concerns that are more than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these.

Benefits of Applying:

  • SBIR & STTR funding can be a leveraging tool to help attract additional funding from other third-party investors.
  • Awards are not loans; no repayment is required.
  • SBIR & STTR funding is non-dilutive capital (i.e., an award does not impact the company’s stock or shares in any way). Intellectual property rights to technologies developed under these programs are retained by the small business concern.
  • SBIR & STTR awards provide recognition, verification, and visibility.

Questions?
Contact the NCI SBIR Development Center at NCIsbir@mail.nih.gov, or a Program Director with the relevant area of expertise, http://sbir.cancer.gov/contact_us.asp.

Please visit http://sbir.cancer.gov/ to learn more about the NCI SBIR & STTR Programs.

The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov